BioSpace News Archive

FDA-approved Ethyol® and Totect® address harmful effects of cancer treatments to help improve the quality of life for oncology patients

The telemedicine consumer experience takes a giant leap forward with a new solution pioneered by an innovative collaboration between Change Healthcare and Doctor On Demand.

As a leading exhibition in Medical Device design and manufacturing in China, Medtec China 2018 will take place 26-28 September 2018 at the Shanghai World EXPO Exhibition & Convention Centre.

Discussion Will Cover Developments with Big Pharma for Strategic Partnerships and Superiority of the LADR™ Platform Over Antibody-Drug Conjugates Conference Call and Webcast to be held on Wednesday, April 18, 2018

Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug Designation to Stealth’s investigational drug candidate, elamipretide, for the treatment of patients with Barth syndrome.

Joint Program for Clinical Research and Clinical Trial Management to be offered through the PAREXEL Academy

Zucara Therapeutics Inc., a diabetes life sciences company advancing the first once-daily therapeutic to prevent low blood glucose levels (hypoglycemia), has secured US$3.9 million in non-dilutive funding from The Leona M. and Harry B. Helmsley Charitable Trust.

Tandem Diabetes Care®, Inc. (NASDAQ: tndm), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced that it has entered into a distribution agreement with Movi SpA to commercialize Tandem’s t:slim X2™ Insulin Pump in Italy.

-- Proceeds to support advancement of integrated portfolio of first-in-class therapeutics for bone marrow transplant --

OncLive®, the leading digital provider of resources and information for oncology professionals, is proud to announce that Beth Y. Karlan, M.D., will be the keynote speaker for the National Fellows Forum on Gynecologic Oncology taking place April 26 to 28 in Miami.